Delivery Order SPE2DB20D3103-SPE2DB24FM9D3
Award Date
3/5/24
Potential Completion Date
3/26/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML pharmaceuticals. The $4,590.10 contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has also received an indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a ceiling value of $1,377.03 and a period of performance through May 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,147.20, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The contract has an ultimate completion date of May 27, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a critical supplier of medical and pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,590.10 contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product, with a performance period through August 13, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,590.10 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award is not set aside and is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML products. The $1,344.27 firm fixed price delivery order contract has an ultimate completion date of October 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.00, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 7, 2025. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, which is a medical product used for healthcare purposes. The award is not designated with a set-aside,...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The $1,377.03 firm fixed price delivery order has a completion date of September 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,295.05 firm fixed-price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FC0E7, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $1,434.00. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 20, 2025. There is no set-aside designation indicated for this...